Form 483

Catalent rebrand Catalent HQ Tampa Florida FL new Catalent HQ headquarters
Manufacturing

FDA hit Catalent's Maryland manufacturing sites with Form 483

The observations tied to two April FDA inspections came before Catalent's layoff spree at its Maryland gene therapy manufacturing business.
Zoey Becker Dec 19, 2025 11:36am
newspaper

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am
FDA

FDA scolds Hetero over missteps at India warehouse

Oct 28, 2025 10:00am
FDA

Novo plant issues may mean delays for Regeneron, Scholar Rock

Oct 13, 2025 3:48pm
FDA

Novo plant acquired in Catalent deal lands in FDA's crosshairs

Aug 22, 2025 10:49am
Eli Lilly

Eli Lilly confirms plan to sell New Jersey plant

Aug 4, 2025 10:50am